Investor Relations

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign me up for company announcements:

Company Overview

We are developing a pipeline of unique small-molecule product candidates, each with several “shots on goal” in both orphan and major cancer markets. Our goal is address shortcomings of approved therapies and improve the lives of cancer patients whose tumors harbor mutations known to be targeted by our product candidates.

Investor Contact Information


Edison Oncology Holding Corp
3475 Edison Way
Suite R
Menlo Park, CA 94025

Investor Relations Counsel

Amato and Partners LLC
New York / San Diego
T: (212) 430-0360